Pfizer to offer encrypted capsule shells

Brand-protection solutions maker NanoGuardian has opened its NanoEncryption technology kimono to Pfizer's Capsugel drug delivery systems division.

By mid-year, Capsugel expects to offer both pre-NanoEncrypted capsule shells and the post-fill nanoscale-marking service. The pre-fill service aims to eliminate significant disruption to a drug maker's existing manufacturing process.

NanoEncryption technology imprints overt, covert and forensic security features on capsules, tablets, vial caps, and single-use syringes to fight counterfeiting and illegal diversion. Overt and covert markings allow dose-level authentication, while forensic NanoCodes provide comprehensive tracing information.

Pharmaceutical Commerce magazine reports that coatings and excipients supplier Colorcon announced a similar deal last summer with ARmark Technologies. In the resulting On-Dose ID offering, the latter's nano-scale microtaggants are added to Colorcon coatings.

Separately, Bilcare has unveiled its nonClonable patient safety system. It uses materials-based fingerprints built from micro- and nano-structures for item-level protection, the company says. The fingerprints are tamper-evident labels themselves, or they can be embedded as tags into objects. A reader device provides authentication in the field via database connection

- here's the Capsugel release
- see the Pharmaceutical Commercs article
- read the Bilcare announcement


Using AI and RWD to Uncover Rare Disease Insights, Accelerate Commercialization and Improve Patient Outcomes

Wednesday, March 24 | 2pm ET / 11am PT

Learn how transformed real world data into real world insights to assist Audentes in their development of AT132 for the treatment of XLMTM. The session reviews how IPM.ia and Audentes collaborated to uncover the XLMTM patient population.